{"id":"NCT02849626","sponsor":"Eisai Inc.","briefTitle":"Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures","officialTitle":"An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-11-16","primaryCompletion":"2019-02-05","completion":"2021-12-06","firstPosted":"2016-07-29","resultsPosted":"2020-04-06","lastUpdate":"2022-10-28"},"enrollment":180,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Partial-Onset or Primary Generalized Tonic-Clonic Seizures"],"interventions":[{"type":"DRUG","name":"Perampanel","otherNames":[]}],"arms":[{"label":"Perampanel","type":"EXPERIMENTAL"}],"summary":"This is an open-label, multicenter study with an Extension Phase to evaluate the safety and tolerability of perampanel oral suspension when administered as an adjunctive therapy in children (ages 4 to less than \\[\\<\\] 12 years) with inadequately controlled partial onset seizures (POS) or primary generalized tonic clonic (PGTC) seizures.","primaryOutcome":{"measure":"Percentage of Participants With Treatment Emergent Adverse Events (AEs) and Treatment Emergent Serious Adverse Events (SAEs) for Total Group of Participants - Core Phase and Extension Phase A of This Study","timeFrame":"Baseline up to 4 weeks (follow up in Extension Phase A) after last dose of study drug in Extension Phase A at Week 52 (up to 56 weeks)","effectByArm":[{"arm":"Perampanel 0.5 mg/mL: All Participants","deltaMin":90,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":24},"locations":{"siteCount":91,"countries":["United States","Belgium","Canada","Czechia","France","Hungary","Italy","Japan","Latvia","Poland","South Korea","Spain"]},"refs":{"pmids":["33839450","31912493"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":29,"n":149},"commonTop":["Nasopharyngitis","Somnolence","Pyrexia","Vomiting","Influenza"]}}